Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

TrichoScan effectively measures hair growth improvements in people using minoxidil.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Changes in scalp microbes may contribute to hair loss, suggesting new treatment options.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Stem cell-derived exosomes could be a promising new treatment for hair regrowth.

Human amniotic stem cell exosomes may effectively treat hair loss by promoting hair regrowth.

Isoproterenol may help treat hair loss by activating hair follicle stem cells.

EX104 effectively promotes hair growth and regenerates follicles in androgenetic alopecia.

Androgenic alopecia can be treated with minoxidil, finasteride, and hormonal therapy.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Loss of COL17A1 causes hair follicle stem cells to age and leads to hair loss.

Changing hair follicle identity could potentially reverse balding.